The COVID-19 pandemic has the potential to consolidate the biotech market, offering highly competitive opportunities for massive growth in an environment of considerable financial challenge. MarketLine: Global Biotechnology
- Microbiome Therapeutics: Global Markets (November,2020)
- Global Markets for Vaccine Technologies (September,2020)
- 3D Cell Cultures: Technologies and Global Markets (August,2020)
- Agricultural Biotechnology: Emerging Technologies and Global Markets (April,2020)
- Induced Pluripotent Stem Cells: Global Markets (February,2020)
- 2019 Biotechnology Research Review (December,2019)
- Up-and-Coming Biotechnology Companies Report (September,2020)
- Innovations in Microbiome, Small Molecules, Biologics, and Biotech Platforms (June,2019)
- Mergers and Acquisitions in the Global Life Sciences Industry 2018 (March,2019)
- Market Guide for Revenue Management in Pharmaceuticals and Biotechnology (April,2020)
- Biotechnology in Australia (October,2020)
- Biotechnology in US (May,2020)
- Animal Health Biotechnology in US (February,2020)
- Biotechnology in Europe (June,2020)
- Biotechnology in Italy (June,2020)
- Biotechnology in Brazil (June,2020)
- Biotechnology in Japan (June,2020)
- Global Biotechnology (June,2020)
- Biotechnology in Germany (June,2020)
- Biotechnology in United Kingdom (June,2020)
- Biotechnology in Asia-Pacific (June,2020)
- Biotechnology in US (June,2020)
- Biotechnology in China (June,2020)
The Market Research Centre is currently working remotely, 9am-5pm. To access the reports above or if you have any queries, email us at market.research@enterprise-ireland.com.
Important note: All our resources are governed by copyright license agreements which vary according to individual publishers.